We recently reported that BRCA1-KO cells were able to “sense” neoplastic factors in the serum of patients with cancers even at early stages and turn malignant regardless of the presence of positive tumor markers (i.e. pancreatic cancer in situ and early colon cancer with negative CEA) [47]. This evidence concerns the gene BRCA1 and cancer.